1/23
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
cancer
diseases of unregulated cell proliferation
malignant
tumor consisting of cells that invade other tissues
metastasis
movement of cells that separate from malignant tumors to other sites where they establish secondary tumors
associated with highly advanced cancers
genetic theory of cancer
many causes of mutations
some cancers are consistently associated with a particular chromosome abnormality
some cancers run in families
Knudsen model
cancer is a multistep process that requires multiple mutations in the same cell
mutations can occur spontaneously or one mutation can be inherited
clonal evolution
mutations that enhance the ability of cells to proliferate predominantly in a clone of cells
increasingly faster in growth
increasingly aggressive in proliferation properties
environmental causes
most cancers are not inherited
environmental exposure to carcinogens and mutagens
examples:
tobacco
diet
alcohol
UV
infections
obesity
occupation
prevalence of cancers varies by location
some cancers have environmental and genetic predisposition interactions
oncogenes
mutates, dominant acting stimulatory genes that cause cancer
mutation in proto-oncogene with or without viral infection
tumor suppressor genes
mutated recessive acting inhibitory genes that are inactive
mutations lead to a loss of heterozygosity
haploinsufficiency
mutant phenotype in an individual cell or organism that is heterozygous for a normally recessive trait
cyclin dependent kinase
combines with cyclin to phosphorylate proteins
phosphorylation can activate or inactivate protein
G1 to S transition
rb binds to transcription factor
cyclins increase in concentration
cyclins combine with CDK’s
rb phosphorylated by CDK’s
transcription factor released
gene needed from replication transcribed
G2 to M transition
cyclin binds with CDK to create inactive MPF
MPF activated by dephosphosphorylation
MPF increases until critical level
MPF phosphorylated proteins for mitosis
MPF decreases initiating anaphase
mutations
RB mutations
apoptosis genes (p53)
autophagy genes (p53)
signal transduction pathways
external signal triggers a cascade of intracellular reactions that produce a specific response
ras proteins coded by oncogenes
receptor components
extracellular domain
transmembrane domain
intracellular domain
levels of miRNA’s
more important in late stage tumor development
less miRNA= higher cancer c
cancer genome project
sequencing of tumors from various cancers
d
drivers
mutation that directly contributes to the development of cancer
proto- oncogenes, tumor suppressor genes, telemorase genes, etc
passengers
mutations that arise randomly in the process of tumor development and do not contribute to cancer progression
evidence
mutations in genes that regulate epigenetic changes in chromatin
cancer cells have different DNA methylation problems
histone acetylation patterns differ
development of colorectal cancer
apc gene mutation= adenomatous polyp formation
mutation in ras gene in larger more advanced polyps
malignant cells have mutation in p53 gene leading to higher mutation rates
deletions
loss of one or more tumor- suppressor genes
inversions and translocations
disrupt function of tumor repressor gene
bring together sequences of genes = fusion protein = increased cell division
move cancer causing genes to new location = activated by new regulatory process